Gram Research analysis of a 2026 study shows that people with inflammatory bowel disease have reduced ability to absorb oxalate, a compound in plant foods like spinach and nuts, causing it to accumulate in the intestines and potentially trigger inflammation. Laboratory mice fed extra oxalate showed increased gut inflammation when they had colitis-like disease, suggesting that for susceptible IBD patients, reducing high-oxalate foods might help reduce intestinal inflammation, though clinical trials are needed to confirm this benefit.
A new study from 2026 explores whether oxalate, a natural compound found in plant foods like spinach and nuts, might make inflammatory bowel disease (IBD) worse in some people. Researchers studied both patients with IBD and mice with similar gut inflammation, measuring how their bodies handle oxalate. They discovered that people with IBD have trouble absorbing oxalate properly, which may trigger stronger immune responses in the gut. The findings suggest that for certain IBD patients, reducing high-oxalate foods might help reduce inflammation, though more research is needed before doctors recommend major dietary changes.
Key Statistics
A 2026 research study published in Cellular and Molecular Gastroenterology and Hepatology found that people with inflammatory bowel disease consistently showed reduced activity of oxalate-absorbing genes (SLC26A2 and SLC26A3) across both Crohn’s disease and ulcerative colitis, regardless of how much oxalate they consumed.
Laboratory mice with experimental colitis fed supplemental oxalate showed increased intestinal inflammation compared to mice on standard diets, according to the 2026 study, suggesting oxalate itself contributes to gut inflammation in susceptible individuals.
Crohn’s disease patients in the 2026 study had elevated stool oxalate levels despite variable dietary intake, indicating the problem stems from impaired intestinal absorption rather than excessive consumption of oxalate-rich foods.
The Quick Take
- What they studied: Whether oxalate, a compound in plant foods, contributes to gut inflammation in people with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis.
- Who participated: The research included people diagnosed with IBD (both Crohn’s disease and ulcerative colitis patients) compared to healthy controls, plus laboratory mice with artificially induced gut inflammation similar to human IBD.
- Key finding: People with IBD have reduced ability to absorb oxalate from their intestines, causing it to build up in their stool. This buildup appears linked to increased gut inflammation, especially when people eat more oxalate-rich foods.
- What it means for you: If you have IBD, tracking your oxalate intake and potentially reducing high-oxalate foods like spinach, almonds, and chocolate might help reduce inflammation. However, this is preliminary evidence, and you should discuss dietary changes with your gastroenterologist before making major adjustments, as oxalate-rich foods also contain important nutrients.
The Research Details
Researchers used multiple approaches to understand oxalate’s role in IBD. First, they measured gene expression (which genes were active or inactive) in intestinal tissue from IBD patients and healthy people, looking specifically at genes that control oxalate absorption. They also analyzed stool samples to measure actual oxalate levels and surveyed patients about their dietary oxalate intake. To confirm their findings, they conducted parallel experiments in laboratory mice with two different types of gut inflammation similar to human IBD. Some mice were fed normal diets while others received extra oxalate to see how it affected their intestinal inflammation. Finally, they studied isolated intestinal cells in dishes to understand the biological mechanisms at work.
This multi-layered approach strengthens confidence in the findings. By studying both human patients and animal models, researchers can identify patterns that appear consistently across different systems. The combination of gene expression data, stool analysis, and dietary intake information helps establish whether oxalate truly contributes to inflammation or is simply a side effect of existing disease.
The study combines human observations with controlled animal experiments, which is a strong research design. The findings were consistent across different IBD types (Crohn’s disease and ulcerative colitis) and different parts of the intestine, suggesting the pattern is robust. However, the study is primarily observational in humans, meaning it shows associations rather than proving cause-and-effect. The exact number of human participants was not specified in the abstract, which limits our ability to assess statistical power. This research should be viewed as important preliminary evidence that warrants follow-up clinical trials.
What the Results Show
The most striking finding was that people with IBD consistently showed reduced activity of two genes called SLC26A2 and SLC26A3 in their intestinal tissue. These genes normally help the body absorb oxalate from food. When these genes are less active, oxalate accumulates in the intestines instead of being absorbed, which appears to trigger inflammatory immune responses. In Crohn’s disease patients specifically, researchers found higher levels of oxalate in stool samples even when patients weren’t eating particularly high-oxalate diets, confirming that the problem stems from absorption, not just intake. When laboratory mice were fed extra oxalate, those with experimental colitis showed increased intestinal inflammation compared to mice on normal diets. This suggests that oxalate itself, not just the inability to absorb it, contributes to inflammation in susceptible individuals.
A third gene called SLC26A6 showed altered expression that correlated with stricturing behavior in Crohn’s disease patients. Stricturing refers to narrowing of the intestine, a serious complication. This suggests that oxalate transporter problems may not only affect inflammation but also influence how the disease progresses and which complications develop. The researchers also noted that dietary oxalate intake varied widely among IBD patients, yet stool oxalate levels remained consistently elevated, reinforcing that the problem is absorption-related rather than dietary.
Previous research established that oxalate activates immune responses in the kidneys and throughout the body, but this is the first study to specifically examine oxalate’s role in intestinal inflammation during IBD. Earlier IBD research has shown that exclusive enteral nutrition (a special liquid diet) and certain exclusion diets can improve symptoms, but the mechanisms weren’t well understood. This study suggests that oxalate may be one dietary component worth investigating as part of those beneficial effects. The findings align with growing evidence that IBD involves complex interactions between genetics, immune function, and diet.
The human portion of this study was observational, meaning researchers observed patterns but cannot definitively prove that oxalate causes inflammation. The exact sample size of human participants wasn’t provided, making it difficult to assess statistical reliability. The study doesn’t establish whether reducing oxalate intake would actually improve symptoms in real IBD patients, only that oxalate levels correlate with inflammation markers. Additionally, oxalate-rich foods like spinach and nuts contain many beneficial nutrients, so simply avoiding them could create nutritional deficiencies. The mouse models, while useful, don’t perfectly replicate human IBD, and findings in mice don’t always translate to humans.
The Bottom Line
For people with IBD, this research suggests considering a moderate reduction in high-oxalate foods as a potential inflammation-management strategy, but only under medical supervision. This is preliminary evidence (moderate confidence level), not yet strong enough for universal dietary recommendations. Work with your gastroenterologist or a dietitian specializing in IBD before making significant dietary changes. High-oxalate foods include spinach, Swiss chard, almonds, peanuts, chocolate, and tea. A balanced approach might involve rotating these foods rather than eliminating them entirely, to maintain nutritional variety.
This research is most relevant to people with diagnosed IBD, particularly those with Crohn’s disease or ulcerative colitis who experience frequent flare-ups. It may be less relevant for people with other digestive conditions or those with well-controlled IBD. Healthy people without IBD should not restrict oxalate intake based on this research, as oxalate-rich plant foods are nutritious and this study shows oxalate only causes problems when absorption is impaired. People with kidney disease or kidney stones should continue following their nephrologist’s oxalate guidance, which may differ from IBD recommendations.
If you and your doctor decide to trial a lower-oxalate diet, expect to observe changes over 4 to 8 weeks. Some people may notice symptom improvement sooner, while others may see no change. This is why tracking is important: keep a food diary and symptom log to determine whether oxalate reduction helps your specific situation. Remember that IBD flare-ups have multiple triggers, so dietary changes alone won’t eliminate all symptoms.
Frequently Asked Questions
Can eating spinach and leafy greens make inflammatory bowel disease worse?
For some IBD patients, yes. A 2026 study found that people with IBD cannot absorb oxalate from leafy greens properly, causing buildup that may trigger inflammation. However, this effect varies by individual, so track your symptoms to determine if these foods affect you personally.
What foods are high in oxalate that I should avoid with IBD?
High-oxalate foods include spinach, Swiss chard, almonds, peanuts, chocolate, and strong tea. However, don’t eliminate them entirely without medical guidance, as they contain important nutrients. Work with a dietitian to identify which specific foods trigger your symptoms.
Does this research mean I should stop eating vegetables if I have Crohn’s disease?
No. This research suggests moderating high-oxalate vegetables, not avoiding all vegetables. Low-oxalate options include lettuce, broccoli, green beans, and carrots. Discuss personalized dietary changes with your gastroenterologist before making major restrictions.
How quickly will reducing oxalate improve my IBD symptoms?
Changes typically appear within 4 to 8 weeks if oxalate is a trigger for you. However, IBD has multiple causes, so dietary changes alone won’t eliminate all symptoms. Track your food and symptoms to determine your personal response.
Is this research strong enough to recommend oxalate restriction to all IBD patients?
Not yet. This 2026 study provides preliminary evidence from human observations and animal models, but clinical trials testing whether oxalate reduction actually improves symptoms are still needed. Consider it a promising avenue to explore with your doctor, not a proven treatment.
Want to Apply This Research?
- Log daily oxalate intake using a food database that includes oxalate content, and correlate it with a symptom severity score (1-10 scale for bloating, pain, and bowel frequency). Track this for 8 weeks to identify your personal oxalate sensitivity pattern.
- Start by identifying which high-oxalate foods trigger your symptoms most noticeably. Use the app to set reminders for lower-oxalate alternatives: swap spinach for lettuce, almonds for sunflower seeds, or dark chocolate for carob. Implement one substitution per week rather than overhauling your diet overnight.
- Create a weekly summary view showing oxalate intake versus symptom scores. Use this data to establish your personal threshold: the oxalate level at which you notice increased inflammation. Share these trends with your healthcare provider during appointments to refine your dietary strategy over time.
This article summarizes research findings and should not replace professional medical advice. Inflammatory bowel disease is a serious condition requiring ongoing care from a gastroenterologist. Before making significant dietary changes, especially restricting food groups, consult with your healthcare provider or a registered dietitian specializing in IBD. This research is preliminary and does not yet constitute standard clinical recommendations. Individual responses to dietary modifications vary widely, and what helps one person may not help another. If you experience severe symptoms, seek immediate medical attention.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.